Beta blockers may reduce mortality in patients with heart and kidney failure. Among 3,503 patients with heart failure initiating dialysis, 60.4% were receiving beta blockers at time of dialysis initiation; 455 died within 6 months. Compared to non-use, beta blocker use was associated with a 21% lower risk of death within 6 months of dialysis initiation after propensity score matching. These findings support use of beta blockers for patients with heart failure initiating dialysis.
###
ARTICLE TITLE: Beta Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis
AUTHORS: Hui Zhou, John J. Sim, Jiaxiao Shi, Sally F. Shaw, Ming-Sum Lee, Jonathan R. Neyer, Csaba P. Kovesdy, Kamyar Kalantar-Zadeh, and Steven J. Jacobsen
DOI: 10.1053/j.ajkd.2020.07.023
Under embargo until 3pm ET on September 30, 2020. Full text of article available by email from media contact.
This part of information is sourced from https://www.eurekalert.org/pub_releases/2020-09/nkf-bbr092320.php